Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase IV, Multicenter, Open Label, Randomized Trial to Compare the Effectiveness and Safety of the Dinoprostone Vaginal Pessary vs Oxytocin for Women Requiring Cervical Ripening Prior to Induction of Labor.

Next Previous
Search
Trial Profile

Phase IV, Multicenter, Open Label, Randomized Trial to Compare the Effectiveness and Safety of the Dinoprostone Vaginal Pessary vs Oxytocin for Women Requiring Cervical Ripening Prior to Induction of Labor.

Status: Discontinued
Phase of Trial: Phase IV

Latest Information Update: 18 Sep 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Dinoprostone; Oxytocin
  • Indications Labour disorders; Labour induction
  • Focus Therapeutic Use
  • Acronyms SOFTNES

    • Most Recent Events

    • 23 Aug 2012 Biomarkers information updated
    • 22 Aug 2012 Actual end date (1 Jan 2012) added as reported by ClinicalTrials.gov record.
    • 16 Jan 2012 Planned End Date changed from 1 Mar 2012 to 1 May 2012 as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top